Comparative Pharmacology
Head-to-head clinical analysis: ANADROL 50 versus MAXIBOLIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ANADROL 50 versus MAXIBOLIN.
ANADROL-50 vs MAXIBOLIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Anabolic steroid; binds to androgen receptors, increasing protein synthesis and promoting nitrogen retention, leading to muscle growth and erythropoietin production.
MAXIBOLIN (methandienone) is an anabolic steroid that binds to androgen receptors, increasing protein synthesis and nitrogen retention in muscle tissue. It also inhibits glucocorticoid receptors, reducing catabolism and promoting anabolic effects.
Adults: 50-200 mg orally once daily for 2-6 weeks, then 2-4 weeks off. Not for continuous use.
Oral: 2 mg three times daily; optimal response may require 4-8 mg daily for 2-3 weeks, then reduce to maintenance of 2-4 mg daily.
None Documented
None Documented
Terminal elimination half-life: 4-6 hours for parent drug; active metabolite 17α-methyl-5α-androstan-3α,17β-diol has half-life ~12-18 hours. Requires multiple daily dosing.
Terminal elimination half-life of 9-10 hours; supports every-other-day dosing in androgen replacement therapy.
Primarily renal: 90% as glucuronide and sulfate conjugates; 6% fecal; <3% unchanged.
Primarily renal (90% as metabolites, 5% unchanged); biliary/fecal elimination accounts for approximately 10%.
Category C
Category C
Anabolic Steroid
Anabolic Steroid